Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

During the Trading Day
125.62 -2.68 / -2.09%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
128.50 +2.88 / +2.29%
 
Volume: 39.2K

Today’s Trading

Previous close128.30
Today’s open128.28
Day’s range125.27 - 128.98
Volume1,785,295
Average volume (3 months)1,522,507
Market cap$31.3B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+38.74%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book28.85

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.76+0.40%
MYLMylan NV+0.89+1.58%
ZTSZoetis Inc-0.45-0.92%
BMRNBiomarin Pharmaceuti...-1.62-1.11%
Data as of 4:05pm ET, 07/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts